RRX REGAL REXNORD CORP Insider Trading

CFO Robert Rehard sold 6,499 RRX shares at $200.00 (5/22/26); holds 27,964 post-sale, down -18.9%. Prior RRX sells 100% well-timed at 90d.

Robert Rehard, EVP and CFO, sold 6,499 shares of Regal Rexnord at $200.00 on 2026-05-22, reducing his holdings by 18.9% and generating $1,299,800.00 in proceeds. His three prior sales at RRX all delivered negative 90-day returns (-10.0%, -10.0%, -1.1%), establishing a 100% well-timed sell pattern at this ticker. Across his cross-ticker open-market history, his sells show an average 90-day return of -7.0% with a 90d well-timed rate of 100.00%, further reinforcing a consistent track record of selling before subsequent declines. With the current price at $209.85 (down -11.2% from the 52-week high of $236.34 and down -4.8% over 90 days), the timing of this sale relative to recent price weakness and his established pattern warrants investor attention as a potential data point in assessing near-term momentum.

EVP Morton Jerrald R sold 9,390 shares of RRX at $209.13 on 2026-05-14 for $1,963,730.70.

Morton Jerrald R, EVP and President of IPS, sold 9,390 shares at $209.13, reducing his holdings from 26,196 shares to 16,806 shares. The sale occurred at a time when Regal Rexnord reported annual revenue of $1.5B with net income of $64.3M, against a backdrop of -1.6% year-over-year revenue decline. With 2 prior sells in his cross-ticker track record and two additional recent sales at RRX on 2026-02-09, this represents a pattern of dispositions at this company. Post-transaction holdings of 16,806 shares remain substantial relative to the broader equity base.

CEO Pinkham sold 39,433 shares (net) in concentrated transactions totaling $8.3M while stock trades below 52-week highs.

CEO Louis V. Pinkham executed a major portfolio reduction on a single day, selling net 39,433 shares while acquiring just 19,433 through two option exercises and one tax withholding settlement. This is Pinkham's sixth through twelfth open-market sale at RRX within a three-year window—a clear pattern of consistent selling with zero open-market purchases. The stock currently trades roughly 13% below its 52-week high and has declined modestly over the past three months. Notably, all five of Pinkham's prior sales at this company were well-timed in hindsight: the stock fell after each exit, confirming his exits avoided subsequent weakness. However, the company remains profitable with solid revenue and has recovered slightly from its worst levels, so this sale occurs against a backdrop of fundamentally stable operations rather than a business in distress. The concentration of multiple sales on a single date, combined with Pinkham's consistent selling pattern and his track record of well-timed exits at this ticker, suggests ongoing portfolio management rather than alarm, though the absence of any open-market purchases in three years warrants attention to whether his confidence in the company's near-term trajectory has diminished.

CFO Robert Rehard sold 2,257 shares (2.3K) of RRX across 2 transactions for $503,478.57, reducing holdings by 6.1%

Robert Rehard, EVP and CFO of Regal Rexnord, executed 2 separate open-market sales totaling 2,257 shares for $503,478.57 at blended average price $223.07 on 2026-02-24 and 2026-02-25, reducing his post-transaction holdings to 34,446 shares. The stock has risen 42.8% over 30 days and 51.2% over 90 days from the transaction dates, and currently trades at $220.80, roughly 1.5% below its 52-week high of $224.08. This represents the insider's first measurable activity at RRX (prior same-ticker history on 2026-02-09 is not yet measurable at 90 days), while his cross-ticker track record shows only 1 prior sell with no established timing pattern. The company's fundamentals show revenue of $1,497,000,000.00 in the latest quarter with net income of $79,600,000.00, though annual revenue growth is -1.6% year-over-year and the P/E ratio stands at 43.12.

CFO Robert Rehard sold 7,704 RRX shares at $216.72; stock at 52-week high with P/E 57.90

Robert Rehard, EVP and CFO, sold 7,704 shares at $216.72 on 2026-02-09, reducing his holdings by 18.4% to 34,153 shares. The transaction occurred at $216.72 while the current price stands at $224.08, placing the trade near the 52-week high of $224.08. With a P/E of 57.90 and annual revenue declining 3.5% year-over-year, the elevated valuation paired with weakening growth creates a material context for the sale, though the 30-day gain of 47.2% reflects recent strong momentum in the stock.

CEO Pinkham sold 36,728 shares of RRX for $7,915,600.80 across 9 transactions on 2026-02-09

Pinkham Louis V., Chief Executive Officer of Regal Rexnord Corp, executed 9 separate sales totaling 36,728 shares for $7,915,600.80 at prices ranging from $210.63 to $217.76, with a blended average of $215.52. This represents a -30.6% reduction in his pre-transaction holdings from 120,065 shares to 83,337 shares post-transaction. The sales occurred on 2026-02-09, the same date as the Form 4 filing, and occurred within 8 cents of the 52-week high of $224.08, with the current price at $224.08 (+0.0% from the high). Within his cross-ticker track record, Pinkham's prior 6 sells averaged +2.0% return at the 90-day mark with a 33.33% well-timed rate, but his 5 prior sales at RRX specifically showed 0 of 2 measurable sales were well-timed at 90 days (the earlier sales returned +10.3% and +9.7%, indicating the stock rose after he sold). The company carries a P/E of 57.90 on $1.5B quarterly revenue with annual revenue declining -3.5% year-over-year, metrics that may warrant scrutiny alongside a substantial CEO liquidation near all-time highs.

EVP Morton sold 7,978 shares at blended $215.77 for $1.7M; post-sale holdings 24.0K shares, -24.9%

Morton Jerrald R, EVP and President of IPS at Regal Rexnord, executed 2 separate sales totaling 7,978 shares for $1,721,445.46 at a blended average price of $215.77, reducing his holdings by 24.9% to 24.0K shares. The stock currently trades at $224.08, above the transaction prices, and has appreciated 47.2% over 30 days and 62.9% over 90 days, reaching its 52-week high of $224.08. This sale occurred amid strong recent price momentum and against a backdrop of -3.5% annual revenue growth and an elevated P/E of 57.90, warranting examination of whether execution by an operating executive reflects fundamental concerns or simply portfolio adjustment.

Director Curtis Stoelting sold 9,000 shares of RRX (RegalRexnord) for $1,710,000 via pre-arranged 10b5-1 trading plan

Curtis W Stoelting, a director, executed 2 separate sales totaling 9,000 shares for $1,710,000 on 2026-02-04 and 2026-02-05 at $180.00 and $200.00 respectively. This sale reduces his holdings from 20,116 shares to 11,116 shares, a net reduction of 44.7% of his pre-transaction position. The transaction was executed under a pre-arranged 10b5-1 trading plan adopted on 2025-02-18, indicating this was a scheduled, non-discretionary sale rather than a discretionary market decision. Because this sale is governed by a 10b5-1 plan, it carries no inference about timing, market confidence, or conviction—the sale was predetermined and executed according to the plan's terms.